In a significant move to curb the growing crisis of substance abuse and public health hazards, the Indian government has officially banned the over-the-counter sale of all cough syrups. This decision follows a widespread investigation by the Food Safety and Drug Administration in Uttar Pradesh, which uncovered a multi-billion-rupee racket involving the illicit distribution of codeine-based syrups. These medicines, often abused for their opioid-like euphoric effects, had become easily accessible, leading to severe addiction issues among the youth and fueling a massive underground network of illegal suppliers that law enforcement agencies are now actively dismantling through nationwide raids.

Beyond the issue of addiction, the mandate serves as a critical safety measure following a series of tragic fatalities linked to contaminated syrups. Both within India and abroad, numerous children and adults have lost their lives due to products laced with toxic industrial solvents like diethylene glycol, which cause rapid kidney failure and metabolic collapse. By requiring a valid doctor’s prescription for every purchase, the Ministry of Health and Family Welfare aims to ensure that these medications are used only for legitimate medical purposes, while state governments intensify their monitoring of pharmaceutical supply chains to prevent the distribution of both hazardous and diverted substances.